Westlake Chemical Partners (WLKP) Financials

$23.05 +0.08 (+0.35%)

Closing price 04/17/2025 03:58 PM Eastern

Extended Trading

$23.05 0.00 (0.00%)

As of 04/17/2025 04:05 PM Eastern

Annual Income Statements for Westlake Chemical Partners

This table shows Westlake Chemical Partners' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Income / (Loss) Attributable to Common Shareholders	510	40	41	49	49	61	66	83	64	54	62
Consolidated Net Income / (Loss)	510	354	353	353	331	333	341	401	335	335	369
Net Income / (Loss) Continuing Operations	510	354	353	353	331	333	341	401	335	335	369
Total Pre-Tax Income	709	355	354	354	331	334	342	402	336	335	370
Total Operating Income	717	359	366	374	350	350	353	411	348	358	390
Total Gross Profit	746	383	391	404	377	379	379	442	377	387	419
Total Revenue	1,750	1,007	854	973	1,075	1,092	967	1,215	1,593	1,191	1,136
Operating Revenue	1,292	835	854	973	1,075	1,092	967	1,215	1,593	1,191	1,136
Total Cost of Revenue	1,004	624	462	569	698	712	588	773	1,216	803	717
Operating Cost of Revenue	1,004	624	462	569	698	712	588	773	1,216	803	717
Total Operating Expenses	29	24	25	29	28	29	26	31	30	30	28
Selling, General & Admin Expense	29	24	25	29	28	29	26	31	30	30	28
Total Other Income / (Expense), net	-7.35	-4.81	-12	-20	-19	-17	-11	-8.75	-12	-22	-20
Interest Expense	10	4.97	13	22	21	20	12	8.82	13	27	26
Other Income / (Expense), net	3.15	0.16	0.60	1.79	2.46	3.10	0.73	0.06	1.57	4.23	5.25
Income Tax Expense	199	0.67	1.04	1.28	0.02	0.73	0.56	0.55	1.02	0.81	0.84
Net Income / (Loss) Attributable to Noncontrolling Interest	-	314	312	304	281	272	275	319	271	280	307
Basic Earnings per Share	-	-	-	$1.43	$1.51	$1.77	$1.88	$2.34	$1.82	$1.54	$1.77
Weighted Average Basic Shares Outstanding	27.06M	27.06M	27.06M	28.39M	32.24M	34.49M	35.20M	35.21M	35.22M	35.22M	35.24M
Diluted Earnings per Share	-	-	-	-	-	-	-	$2.34	$1.82	$1.54	$1.77
Weighted Average Diluted Shares Outstanding	27.06M	27.06M	27.06M	28.39M	32.24M	34.49M	35.20M	35.21M	35.22M	35.22M	35.24M
Weighted Average Basic & Diluted Shares Outstanding	27.06M	27.06M	27.06M	28.39M	32.24M	34.49M	35.20M	35.21M	35.22M	35.22M	35.23M
Cash Dividends to Common per Share	-	$1.15	$1.29	$1.44	$1.61	$1.80	$1.89	$1.89	$1.89	$1.89	$1.89

This table shows Westlake Chemical Partners' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Income / (Loss) Attributable to Common Shareholders	15	17	15	12	13	14	15	14	18	15
Consolidated Net Income / (Loss)	78	91	91	75	81	87	90	88	104	87
Net Income / (Loss) Continuing Operations	78	91	91	75	81	87	90	88	104	87
Total Pre-Tax Income	79	91	92	75	81	87	90	88	104	88
Total Operating Income	82	95	98	80	86	93	95	94	110	92
Total Gross Profit	90	98	106	88	93	101	102	101	117	99
Total Revenue	415	367	308	264	322	297	285	284	277	290
Operating Revenue	415	367	308	264	322	297	285	284	277	290
Total Cost of Revenue	325	269	202	176	229	197	182	183	160	191
Operating Cost of Revenue	325	269	202	176	229	197	182	183	160	191
Total Operating Expenses	8.68	2.85	7.91	7.23	6.74	7.87	7.08	7.61	7.25	6.56
Selling, General & Admin Expense	8.68	2.85	7.91	7.23	6.74	7.87	7.08	7.61	7.25	6.56
Total Other Income / (Expense), net	-3.03	-3.82	-6.50	-5.06	-5.17	-5.55	-5.25	-5.39	-5.37	-4.44
Interest Expense	3.65	4.70	7.32	6.12	6.44	6.63	6.58	6.65	6.70	5.77
Other Income / (Expense), net	0.62	0.88	0.82	1.06	1.27	1.08	1.33	1.26	1.33	1.34
Income Tax Expense	0.48	0.20	0.21	0.17	0.22	0.21	0.21	0.21	0.22	0.20
Net Income / (Loss) Attributable to Noncontrolling Interest	64	74	77	63	68	73	75	74	86	72
Basic Earnings per Share	$0.42	$0.47	$0.42	$0.34	$0.37	$0.41	$0.42	$0.41	$0.51	$0.43
Weighted Average Basic Shares Outstanding	35.22M	35.22M	35.22M	35.22M	35.23M	35.22M	35.23M	35.23M	35.24M	35.24M
Diluted Earnings per Share	$0.42	$0.47	$0.42	$0.34	$0.37	$0.41	$0.42	$0.41	$0.51	$0.43
Weighted Average Diluted Shares Outstanding	35.22M	35.22M	35.22M	35.22M	35.23M	35.22M	35.23M	35.23M	35.24M	35.24M
Weighted Average Basic & Diluted Shares Outstanding	35.22M	35.22M	35.22M	35.22M	35.23M	35.22M	35.23M	35.23M	35.24M	35.23M

This table details how cash moves in and out of Westlake Chemical Partners' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Change in Cash & Equivalents	134	36	-81	-62	-7.26	0.18	-2.77	-0.10	48	-6.16	-0.30
Net Cash From Operating Activities	604	453	288	537	436	451	373	408	464	452	485
Net Cash From Continuing Operating Activities	604	453	288	537	436	451	373	408	464	452	485
Net Income / (Loss) Continuing Operations	510	354	353	353	331	333	341	401	335	335	369
Consolidated Net Income / (Loss)	510	354	353	353	331	333	341	401	335	335	369
Depreciation Expense	78	81	98	114	109	107	103	109	121	110	112
Non-Cash Adjustments To Reconcile Net Income	2.68	1.53	3.76	1.99	1.50	0.06	0.73	3.92	5.06	4.91	2.16
Changes in Operating Assets and Liabilities, net	14	16	-168	68	-4.76	11	-72	-106	2.77	2.26	1.78
Net Cash From Investing Activities	-203	-231	-299	-203	-52	-58	2.03	-64	-12	-76	-89
Net Cash From Continuing Investing Activities	-203	-231	-299	-203	-52	-58	2.03	-64	-12	-76	-89
Purchase of Property, Plant & Equipment	-203	-231	-300	-69	-40	-44	-37	-81	-54	-47	-49
Purchase of Investments	-0.13	-	0.00	-199	-384	-529	-349	-276	-320	-174	-40
Sale and/or Maturity of Investments	-	-	0.00	63	372	515	388	293	362	145	0.00
Net Cash From Financing Activities	-267	-186	-69	-396	-392	-393	-378	-344	-404	-382	-396
Net Cash From Continuing Financing Activities	-267	-186	-69	-396	-392	-393	-378	-344	-404	-382	-396
Repayment of Debt	-79	-135	-1.55	-286	0.00	-201	0.00	0.00	-32	-209	-219
Payment of Dividends	-656	-342	-280	-386	-395	-378	-378	-344	-404	-382	-396
Issuance of Debt	182	292	212	165	3.65	124	0.00	0.00	32	209	219

This table details how cash moves in and out of Westlake Chemical Partners' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Change in Cash & Equivalents	1.10	45	40	-45	6.44	-7.25	-2.86	10	-5.79	-1.89
Net Cash From Operating Activities	115	123	145	99	101	108	105	122	126	132
Net Cash From Continuing Operating Activities	115	123	145	99	101	108	105	122	126	132
Net Income / (Loss) Continuing Operations	78	91	91	75	81	87	90	88	104	87
Consolidated Net Income / (Loss)	78	91	91	75	81	87	90	88	104	87
Depreciation Expense	29	29	27	27	28	28	28	28	28	27
Non-Cash Adjustments To Reconcile Net Income	1.99	-3.73	0.94	-0.22	3.63	0.55	0.53	1.34	0.36	-0.06
Changes in Operating Assets and Liabilities, net	5.81	5.65	26	-3.54	-12	-8.24	-14	4.21	-6.50	18
Net Cash From Investing Activities	-19	62	0.23	-47	-6.81	-23	-9.77	-10	-31	-38
Net Cash From Continuing Investing Activities	-19	62	0.23	-47	-6.81	-23	-9.77	-10	-31	-38
Purchase of Property, Plant & Equipment	-13	-8.66	-13	-4.51	-17	-13	-9.77	-10	-16	-13
Purchase of Investments	-106	-44	-90	-74	-	-10	0.00	-	-15	-25
Net Cash From Financing Activities	-95	-140	-105	-97	-88	-92	-98	-101	-101	-96
Net Cash From Continuing Financing Activities	-95	-140	-105	-97	-88	-92	-98	-101	-101	-96
Repayment of Debt	-	-32	-39	-60	-57	-54	-54	-54	-55	-56
Payment of Dividends	-95	-140	-105	-97	-88	-92	-98	-101	-101	-96
Issuance of Debt	-	32	39	60	57	54	54	54	55	56

This table presents Westlake Chemical Partners' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total Assets	1,096	1,290	1,555	1,515	1,462	1,393	1,356	1,481	1,372	1,317	1,288
Total Current Assets	197	225	232	231	247	238	263	281	246	226	241
Cash & Equivalents	134	170	89	27	20	20	17	17	65	59	58
Short-Term Investments	-	-	-	-	149	-	123	-	-	94	135
Accounts Receivable	56	52	139	62	74	53	119	149	111	68	44
Inventories, net	6.63	3.88	3.93	5.59	4.39	2.48	3.47	8.90	4.72	4.43	4.06
Prepaid Expenses	0.21	0.27	0.27	0.31	0.37	0.47	0.39	0.40	0.31	0.44	0.44
Plant, Property, & Equipment, net	842	1,020	1,222	1,196	1,148	1,103	1,051	1,044	990	944	904
Total Noncurrent Assets	58	45	101	88	67	52	43	156	136	147	143
Goodwill	5.81	5.81	5.81	5.81	5.81	5.81	5.81	5.81	5.81	5.81	5.81
Other Noncurrent Operating Assets	52	39	95	82	61	46	37	150	130	141	138
Total Liabilities & Shareholders' Equity	1,096	1,290	1,555	1,515	1,462	1,393	1,356	1,481	1,372	1,317	1,288
Total Liabilities	261	443	634	517	528	441	441	508	468	461	459
Total Current Liabilities	32	58	38	40	49	39	40	107	67	56	55
Accounts Payable	20	34	22	25	33	21	21	46	49	31	38
Accrued Expenses	12	23	16	16	16	18	19	61	18	25	17
Total Noncurrent Liabilities	230	385	596	476	479	402	402	401	401	404	403
Long-Term Debt	-	-	-	-	-	-	-	-	400	400	400
Noncurrent Deferred & Payable Income Tax Liabilities	1.85	1.39	1.74	2.22	1.66	1.65	1.54	1.53	1.66	1.63	1.55
Other Noncurrent Operating Liabilities	0.02	0.09	0.12	0.11	0.00	1.15	0.38	-	0.00	2.95	2.05
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	835	847	921	999	934	1,265	915	973	904	856	829
Total Preferred & Common Equity	88	97	103	220	216	590	313	294	292	280	276
Total Common Equity	88	97	103	220	216	590	277	294	292	280	276
Common Stock	88	97	102	220	216	590	313	294	292	280	276
Noncontrolling Interest	747	751	818	779	718	675	638	679	612	576	553

This table presents Westlake Chemical Partners' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Total Assets	1,343	1,336	1,342	1,295	1,288	1,295
Total Current Assets	232	221	231	224	232	242
Cash & Equivalents	105	59	66	56	66	60
Short-Term Investments	52	94	-	-	-	110
Accounts Receivable	70	63	76	69	66	67
Inventories, net	5.47	3.26	4.39	4.86	4.49	3.75
Prepaid Expenses	0.15	0.72	0.60	0.26	0.94	0.67
Plant, Property, & Equipment, net	977	963	959	927	913	909
Total Noncurrent Assets	133	152	151	144	143	144
Goodwill	5.81	5.81	5.81	5.81	5.81	5.81
Other Noncurrent Operating Assets	127	146	145	138	138	138
Total Liabilities & Shareholders' Equity	1,343	1,336	1,342	1,295	1,288	1,295
Total Liabilities	453	468	480	447	454	457
Total Current Liabilities	51	66	76	43	50	53
Accounts Payable	30	39	44	23	28	32
Accrued Expenses	21	27	31	20	22	21
Total Noncurrent Liabilities	401	401	405	404	404	404
Long-Term Debt	-	400	400	400	400	400
Noncurrent Deferred & Payable Income Tax Liabilities	1.64	1.64	1.66	1.66	1.68	1.57
Other Noncurrent Operating Liabilities	-	-	3.31	2.41	2.55	2.35
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	890	868	861	848	835	838
Total Preferred & Common Equity	290	286	282	278	276	278
Total Common Equity	290	286	282	278	276	278
Common Stock	290	286	282	278	276	278
Noncontrolling Interest	600	582	579	570	559	560

This table displays calculated financial ratios and metrics derived from Westlake Chemical Partners' official financial filings.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	0.00%	-42.43%	-15.24%	13.98%	10.47%	1.57%	-11.47%	25.67%	31.14%	-25.26%	-4.61%
EBITDA Growth	0.00%	-44.73%	5.57%	5.36%	-5.98%	-0.07%	-0.80%	13.72%	-9.48%	0.39%	7.51%
EBIT Growth	0.00%	-50.05%	2.10%	2.49%	-6.43%	0.35%	0.13%	16.12%	-14.97%	3.63%	9.33%
NOPAT Growth	0.00%	-30.37%	1.87%	2.10%	-6.30%	-0.05%	0.86%	16.38%	-15.48%	2.94%	9.17%
Net Income Growth	0.00%	-30.59%	-0.13%	-0.10%	-6.37%	0.70%	2.47%	17.67%	-16.58%	-0.06%	10.32%
EPS Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-22.22%	-15.38%	14.94%
Operating Cash Flow Growth	0.00%	-25.08%	-36.42%	86.76%	-18.83%	3.36%	-17.17%	9.38%	13.54%	-2.53%	7.30%
Free Cash Flow Firm Growth	0.00%	0.00%	-99.87%	119,533.77%	55.99%	-52.83%	95.73%	-55.04%	102.12%	6.31%	-7.36%
Invested Capital Growth	0.00%	14.29%	34.39%	1.33%	-14.02%	7.15%	-11.82%	15.40%	-8.61%	-10.96%	-6.05%
Revenue Q/Q Growth	0.00%	0.00%	-9.30%	-1.36%	13.21%	8.12%	-4.75%	2.00%	0.00%	-5.52%	-0.63%
EBITDA Q/Q Growth	0.00%	0.00%	3.71%	0.15%	-3.47%	2.09%	-4.24%	13.99%	0.00%	-0.71%	-0.27%
EBIT Q/Q Growth	0.00%	0.00%	1.80%	1.07%	-4.29%	2.66%	-5.02%	18.17%	0.00%	-0.62%	-0.14%
NOPAT Q/Q Growth	0.00%	0.00%	1.75%	1.14%	-4.48%	2.73%	-4.88%	18.18%	0.00%	-0.69%	-0.20%
Net Income Q/Q Growth	0.00%	0.00%	0.69%	1.36%	-4.82%	3.20%	-4.69%	18.71%	0.00%	-1.24%	0.09%
EPS Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-3.75%	1.14%
Operating Cash Flow Q/Q Growth	0.00%	0.74%	-3.68%	4.90%	-6.29%	2.15%	-18.21%	-2.54%	0.00%	-3.19%	5.39%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	8.08%	34.83%	-54.37%	117.72%	-39.09%	-63.97%	158.94%	-11.86%
Invested Capital Q/Q Growth	0.00%	0.00%	1.04%	-0.53%	-11.83%	12.98%	-10.70%	5.40%	0.00%	-7.72%	-2.96%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	42.63%	38.01%	45.84%	41.48%	35.09%	34.75%	39.19%	36.36%	23.69%	32.54%	36.88%
EBITDA Margin	45.57%	43.75%	54.50%	50.37%	42.87%	42.18%	47.26%	42.77%	29.52%	39.65%	44.69%
Operating Margin	40.95%	35.68%	42.92%	38.48%	32.52%	32.07%	36.52%	33.81%	21.82%	30.04%	34.37%
EBIT Margin	41.13%	35.69%	42.99%	38.66%	32.75%	32.35%	36.59%	33.81%	21.92%	30.39%	34.84%
Profit (Net Income) Margin	29.14%	35.13%	41.40%	36.28%	30.75%	30.49%	35.29%	33.04%	21.02%	28.10%	32.50%
Tax Burden Percent	71.89%	99.81%	99.71%	99.64%	99.99%	99.78%	99.83%	99.86%	99.70%	99.76%	99.77%
Interest Burden Percent	98.54%	98.62%	96.57%	94.19%	93.91%	94.44%	96.60%	97.85%	96.16%	92.68%	93.50%
Effective Tax Rate	28.11%	0.19%	0.29%	0.36%	0.01%	0.22%	0.17%	0.14%	0.30%	0.24%	0.23%
Return on Invested Capital (ROIC)	55.46%	36.04%	29.37%	25.98%	26.00%	27.14%	28.12%	32.42%	26.73%	30.48%	36.43%
ROIC Less NNEP Spread (ROIC-NNEP)	49.83%	32.92%	26.04%	21.78%	20.98%	18.37%	21.20%	29.70%	23.44%	22.84%	27.43%
Return on Net Nonoperating Assets (RNNOA)	5.60%	6.03%	10.60%	10.80%	8.20%	3.14%	3.17%	10.10%	8.96%	7.55%	7.38%
Return on Equity (ROE)	61.06%	42.07%	39.96%	36.77%	34.20%	30.28%	31.30%	42.52%	35.69%	38.03%	43.80%
Cash Return on Invested Capital (CROIC)	0.00%	22.70%	0.02%	24.65%	41.08%	20.23%	40.69%	18.12%	35.73%	42.07%	42.67%
Operating Return on Assets (OROA)	67.33%	30.12%	25.80%	24.50%	23.65%	24.74%	25.73%	28.95%	24.49%	26.92%	30.38%
Return on Assets (ROA)	47.69%	29.65%	24.84%	23.00%	22.21%	23.32%	24.81%	28.29%	23.47%	24.89%	28.34%
Return on Common Equity (ROCE)	25.69%	4.61%	4.51%	6.18%	7.71%	11.10%	12.46%	12.87%	11.14%	12.36%	14.45%
Return on Equity Simple (ROE_SIMPLE)	582.49%	365.40%	344.17%	160.41%	153.18%	56.40%	109.12%	136.54%	114.70%	119.54%	133.69%
Net Operating Profit after Tax (NOPAT)	515	359	365	373	350	349	352	410	347	357	390
NOPAT Margin	29.44%	35.61%	42.80%	38.34%	32.52%	32.00%	36.46%	33.76%	21.76%	29.97%	34.30%
Net Nonoperating Expense Percent (NNEP)	5.63%	3.12%	3.33%	4.20%	5.02%	8.77%	6.92%	2.72%	3.29%	7.64%	9.00%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-	26.60%	28.41%	31.70%
Cost of Revenue to Revenue	57.37%	61.99%	54.16%	58.52%	64.91%	65.25%	60.81%	63.64%	76.31%	67.46%	63.12%
SG&A Expenses to Revenue	1.67%	2.34%	2.92%	3.01%	2.57%	2.68%	2.68%	2.55%	1.86%	2.50%	2.51%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	1.67%	2.34%	2.92%	3.01%	2.57%	2.68%	2.68%	2.55%	1.86%	2.50%	2.51%
Earnings before Interest and Taxes (EBIT)	720	359	367	376	352	353	354	411	349	362	396
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	797	441	465	490	461	461	457	520	470	472	508
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	4.57	3.34	3.28	1.97	2.36	1.09	2.35	2.69	2.35	2.46	2.90
Price to Tangible Book Value (P/TBV)	4.90	3.56	3.48	2.02	2.42	1.10	2.40	2.75	2.40	2.51	2.96
Price to Revenue (P/Rev)	0.23	0.32	0.39	0.44	0.47	0.59	0.68	0.65	0.43	0.58	0.70
Price to Earnings (P/E)	0.79	8.13	8.23	8.89	10.31	10.58	9.87	9.59	10.71	12.68	12.82
Dividend Yield	1.15%	9.60%	10.33%	9.45%	10.22%	9.62%	10.16%	8.39%	9.66%	9.65%	8.31%
Earnings Yield	127.32%	12.30%	12.15%	11.25%	9.70%	9.45%	10.13%	10.43%	9.34%	7.89%	7.80%
Enterprise Value to Invested Capital (EV/IC)	1.09	0.85	0.75	0.82	0.85	0.98	0.98	1.07	1.32	1.37	1.51
Enterprise Value to Revenue (EV/Rev)	0.58	0.90	1.25	1.22	0.98	1.19	1.19	1.20	1.03	1.27	1.37
Enterprise Value to EBITDA (EV/EBITDA)	1.27	2.05	2.29	2.42	2.30	2.82	2.52	2.80	3.47	3.20	3.07
Enterprise Value to EBIT (EV/EBIT)	1.41	2.52	2.91	3.15	3.01	3.68	3.25	3.54	4.68	4.18	3.94
Enterprise Value to NOPAT (EV/NOPAT)	1.97	2.52	2.92	3.18	3.03	3.72	3.26	3.54	4.71	4.24	4.00
Enterprise Value to Operating Cash Flow (EV/OCF)	1.68	2.00	3.71	2.20	2.43	2.88	3.08	3.56	3.52	3.34	3.22
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	4.01	3,603.99	3.35	1.92	4.99	2.26	6.34	3.53	3.07	3.42
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.44	0.47	0.48
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.44	0.47	0.48
Financial Leverage	0.11	0.18	0.41	0.50	0.39	0.17	0.15	0.34	0.38	0.33	0.27
Leverage Ratio	1.66	1.42	1.61	1.60	1.54	1.30	1.26	1.50	1.52	1.53	1.55
Compound Leverage Factor	1.63	1.40	1.55	1.51	1.45	1.23	1.22	1.47	1.46	1.42	1.45
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	30.66%	31.82%	32.52%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	30.66%	31.82%	32.52%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	89.52%	88.57%	88.85%	77.97%	76.90%	53.34%	69.69%	69.78%	46.94%	45.89%	45.01%
Common Equity to Total Capital	10.48%	11.43%	11.15%	22.03%	23.10%	46.66%	30.31%	30.22%	22.40%	22.29%	22.47%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.85	0.85	0.79
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.71	0.52	0.41
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.85	0.85	0.79
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.15	1.12	1.03
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.97	0.69	0.53
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.15	1.12	1.03
Altman Z-Score	4.86	2.29	1.80	2.12	2.27	2.67	2.66	2.81	3.04	2.86	3.12
Noncontrolling Interest Sharing Ratio	57.92%	89.04%	88.72%	83.19%	77.45%	63.34%	60.20%	69.73%	68.78%	67.51%	67.01%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	6.15	3.90	6.15	5.75	5.07	6.14	6.62	2.63	3.67	4.02	4.35
Quick Ratio	5.93	3.83	6.03	2.21	4.97	1.87	6.53	1.55	2.63	3.93	4.27
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	226	0.30	354	552	260	510	229	463	493	456
Operating Cash Flow to CapEx	297.80%	195.75%	96.02%	780.38%	1,094.15%	1,031.43%	1,010.05%	503.18%	856.90%	965.38%	990.38%
Free Cash Flow to Firm to Interest Expense	0.00	45.48	0.02	16.20	25.77	13.27	42.35	26.00	34.56	18.59	17.75
Operating Cash Flow to Interest Expense	57.53	91.11	22.82	24.58	20.35	22.97	31.02	46.33	34.59	17.06	18.87
Operating Cash Flow Less CapEx to Interest Expense	38.21	44.57	-0.94	21.43	18.49	20.75	27.95	37.12	30.55	15.29	16.97
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.64	0.84	0.60	0.63	0.72	0.76	0.70	0.86	1.12	0.89	0.87
Accounts Receivable Turnover	27.37	18.72	8.96	9.68	15.85	17.27	11.25	9.08	12.27	13.29	20.32
Inventory Turnover	16.32	118.77	118.36	119.57	139.87	207.35	197.31	124.98	178.62	175.65	168.89
Fixed Asset Turnover	2.18	1.08	0.76	0.80	0.92	0.97	0.90	1.16	1.57	1.23	1.23
Accounts Payable Turnover	14.08	22.97	16.41	24.44	24.46	26.45	27.77	23.12	25.51	19.89	20.54
Days Sales Outstanding (DSO)	13.34	19.50	40.75	37.70	23.03	21.13	32.44	40.21	29.74	27.47	17.97
Days Inventory Outstanding (DIO)	22.36	3.07	3.08	3.05	2.61	1.76	1.85	2.92	2.04	2.08	2.16
Days Payable Outstanding (DPO)	25.93	15.89	22.24	14.94	14.92	13.80	13.14	15.79	14.31	18.35	17.77
Cash Conversion Cycle (CCC)	9.77	6.68	21.60	25.82	10.72	9.10	21.15	27.34	17.48	11.20	2.36
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	929	1,062	1,427	1,446	1,243	1,332	1,174	1,355	1,239	1,103	1,036
Invested Capital Turnover	1.88	1.01	0.69	0.68	0.80	0.85	0.77	0.96	1.23	1.02	1.06
Increase / (Decrease) in Invested Capital	0.00	133	365	19	-203	89	-157	181	-117	-136	-67
Enterprise Value (EV)	1,014	905	1,067	1,185	1,058	1,300	1,150	1,453	1,634	1,511	1,560
Market Capitalization	400	324	337	433	509	645	653	792	687	688	800
Book Value per Share	$3.23	$3.58	$3.79	$6.83	$6.69	$16.77	$7.88	$8.35	$8.29	$7.95	$7.84
Tangible Book Value per Share	$3.02	$3.36	$3.58	$6.65	$6.51	$16.61	$7.72	$8.18	$8.12	$7.78	$7.67
Total Capital	835	847	921	999	934	1,265	915	973	1,303	1,256	1,229
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	400	400	400
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	400	400	400
Net Debt	-134	-170	-89	-27	-169	-20	-140	-17	335	247	207
Capital Expenditures (CapEx)	203	231	300	69	40	44	37	81	54	47	49
Debt-free, Cash-free Net Working Capital (DFCFNWC)	31	-1.97	105	164	30	180	83	157	114	17	-7.32
Debt-free Net Working Capital (DFNWC)	165	168	194	191	198	200	224	174	179	170	186
Net Working Capital (NWC)	165	168	194	191	198	200	224	174	179	170	186
Net Nonoperating Expense (NNE)	5.28	4.80	12	20	19	16	11	8.74	12	22	20
Net Nonoperating Obligations (NNO)	94	214	506	447	309	67	259	383	335	247	207
Total Depreciation and Amortization (D&A)	78	81	98	114	109	107	103	109	121	110	112
Debt-free, Cash-free Net Working Capital to Revenue	1.77%	-0.20%	12.36%	16.87%	2.76%	16.45%	8.60%	12.95%	7.16%	1.41%	-0.64%
Debt-free Net Working Capital to Revenue	9.41%	16.64%	22.77%	19.64%	18.45%	18.28%	23.13%	14.36%	11.23%	14.27%	16.34%
Net Working Capital to Revenue	9.41%	16.64%	22.77%	19.64%	18.45%	18.28%	23.13%	14.36%	11.23%	14.27%	16.34%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$1.47	$0.00	$0.00	$0.00	$0.00	$1.88	$2.34	$1.82	$1.54	$1.77
Adjusted Weighted Average Basic Shares Outstanding	27.06M	27.06M	27.06M	32.24M	32.25M	35.19M	70.40M	70.43M	35.22M	35.23M	35.24M
Adjusted Diluted Earnings per Share	$0.00	$1.47	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$1.54	$1.77
Adjusted Weighted Average Diluted Shares Outstanding	27.06M	27.06M	27.06M	32.24M	32.25M	35.19M	70.40M	70.43M	35.22M	35.23M	35.24M
Adjusted Basic & Diluted Earnings per Share	$0.00	$1.47	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	27.06M	27.06M	27.06M	28.39M	32.24M	34.49M	35.20M	35.21M	35.22M	35.22M	35.23M
Normalized Net Operating Profit after Tax (NOPAT)	515	359	365	373	350	349	352	410	347	357	390
Normalized NOPAT Margin	29.44%	35.61%	42.80%	38.34%	32.52%	32.00%	36.46%	33.76%	21.76%	29.97%	34.30%
Pre Tax Income Margin	40.53%	35.20%	41.52%	36.41%	30.75%	30.56%	35.35%	33.08%	21.08%	28.17%	32.57%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	68.55	72.38	29.11	17.21	16.42	18.00	29.38	46.59	26.05	13.66	15.40
NOPAT to Interest Expense	49.06	72.21	28.98	17.06	16.31	17.80	29.27	46.52	25.85	13.47	15.16
EBIT Less CapEx to Interest Expense	49.23	25.83	5.35	14.06	14.56	15.77	26.31	37.38	22.01	11.89	13.49
NOPAT Less CapEx to Interest Expense	29.74	25.66	5.21	13.92	14.45	15.58	26.20	37.31	21.82	11.70	13.25
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	128.69%	96.63%	79.10%	109.34%	119.57%	113.44%	110.87%	85.76%	120.66%	114.22%	107.36%
Augmented Payout Ratio	128.69%	96.63%	79.10%	109.34%	119.57%	113.44%	110.87%	85.76%	120.66%	114.22%	107.36%

This table displays calculated financial ratios and metrics derived from Westlake Chemical Partners' official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	0.00%	0.00%	-15.10%	-41.14%	-22.51%	-18.96%	-7.48%	7.57%	-13.89%	-2.43%
EBITDA Growth	18.03%	0.00%	9.74%	-8.35%	3.50%	-2.67%	-0.94%	13.45%	20.21%	-1.11%
EBIT Growth	20.94%	0.00%	18.98%	-6.77%	6.16%	-2.35%	-2.57%	16.35%	26.86%	-0.57%
NOPAT Growth	19.15%	0.00%	17.93%	-7.91%	5.77%	-2.60%	-3.12%	16.31%	27.28%	-0.85%
Net Income Growth	0.00%	0.00%	13.15%	-10.87%	3.25%	-4.61%	-1.97%	16.96%	28.75%	0.38%
EPS Growth	0.00%	0.00%	-8.70%	-27.66%	-11.90%	-12.77%	0.00%	20.59%	37.84%	4.88%
Operating Cash Flow Growth	16.12%	0.00%	38.21%	-18.46%	-12.62%	-12.16%	-27.82%	23.70%	24.92%	23.03%
Free Cash Flow Firm Growth	1,301.16%	217.08%	58.16%	-6.43%	-181.12%	7.81%	-83.08%	-79.25%	121.35%	-30.56%
Invested Capital Growth	-100.00%	-8.61%	-9.04%	-8.76%	0.00%	-10.96%	5.23%	4.90%	-10.66%	-6.05%
Revenue Q/Q Growth	-7.50%	-11.63%	-16.13%	-14.14%	21.76%	-7.58%	-4.24%	-0.18%	-2.52%	4.72%
EBITDA Q/Q Growth	-5.62%	12.27%	0.05%	-13.55%	6.58%	5.58%	1.83%	-0.99%	12.93%	-13.14%
EBIT Q/Q Growth	-5.76%	16.65%	2.93%	-17.60%	7.31%	7.29%	2.71%	-1.61%	17.00%	-15.90%
NOPAT Q/Q Growth	-6.75%	16.92%	3.01%	-18.00%	7.09%	7.67%	2.47%	-1.55%	17.19%	-16.12%
Net Income Q/Q Growth	-7.26%	16.54%	0.21%	-17.70%	7.43%	7.67%	2.97%	-1.81%	18.26%	-16.05%
EPS Q/Q Growth	-10.64%	11.90%	-10.64%	-19.05%	8.82%	10.81%	2.44%	-2.38%	24.39%	-15.69%
Operating Cash Flow Q/Q Growth	-4.44%	6.13%	18.18%	-31.97%	2.42%	6.68%	-2.88%	16.57%	3.43%	5.07%
Free Cash Flow Firm Q/Q Growth	583.29%	-84.51%	-0.61%	-11.06%	-692.38%	120.59%	-73.41%	9.12%	509.47%	-33.04%
Invested Capital Q/Q Growth	-100.00%	0.00%	-8.54%	-1.67%	7.28%	-7.72%	-0.43%	-1.98%	-8.62%	-2.96%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	21.80%	26.75%	34.48%	33.21%	28.91%	33.87%	35.89%	35.62%	42.22%	33.99%
EBITDA Margin	26.94%	34.23%	40.83%	41.11%	35.98%	41.11%	43.71%	43.35%	50.23%	41.66%
Operating Margin	19.71%	25.97%	31.90%	30.47%	26.81%	31.22%	33.41%	32.95%	39.60%	31.73%
EBIT Margin	19.86%	26.21%	32.17%	30.87%	27.21%	31.59%	33.88%	33.39%	40.08%	32.19%
Profit (Net Income) Margin	18.86%	24.88%	29.72%	28.49%	25.14%	29.29%	31.49%	30.98%	37.58%	30.13%
Tax Burden Percent	99.39%	99.79%	99.77%	99.77%	99.73%	99.76%	99.77%	99.77%	99.79%	99.77%
Interest Burden Percent	95.58%	95.11%	92.61%	92.50%	92.64%	92.94%	93.18%	92.99%	93.97%	93.82%
Effective Tax Rate	0.61%	0.21%	0.23%	0.23%	0.27%	0.24%	0.23%	0.23%	0.21%	0.23%
Return on Invested Capital (ROIC)	0.00%	31.84%	41.18%	35.25%	56.40%	31.68%	33.48%	34.21%	39.93%	33.62%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	30.77%	38.65%	33.23%	53.31%	29.78%	31.70%	32.35%	38.02%	31.67%
Return on Net Nonoperating Assets (RNNOA)	0.00%	11.77%	10.61%	9.01%	20.66%	9.84%	10.70%	11.01%	12.62%	8.52%
Return on Equity (ROE)	0.00%	43.60%	51.79%	44.26%	77.06%	41.52%	44.18%	45.23%	52.54%	42.14%
Cash Return on Invested Capital (CROIC)	200.00%	35.73%	39.87%	39.53%	-139.87%	42.07%	25.33%	27.37%	45.76%	42.67%
Operating Return on Assets (OROA)	0.00%	29.28%	35.39%	29.88%	51.12%	27.98%	30.00%	30.23%	34.76%	28.07%
Return on Assets (ROA)	0.00%	27.79%	32.70%	27.57%	47.23%	25.94%	27.88%	28.04%	32.59%	26.28%
Return on Common Equity (ROCE)	0.00%	13.61%	16.20%	13.95%	25.25%	13.49%	14.45%	14.91%	17.32%	13.90%
Return on Equity Simple (ROE_SIMPLE)	0.00%	0.00%	119.03%	117.79%	120.05%	0.00%	119.65%	125.20%	132.79%	0.00%
Net Operating Profit after Tax (NOPAT)	81	95	98	80	86	93	95	93	109	92
NOPAT Margin	19.59%	25.92%	31.83%	30.40%	26.74%	31.15%	33.33%	32.87%	39.52%	31.65%
Net Nonoperating Expense Percent (NNEP)	1.58%	1.06%	2.53%	2.03%	3.09%	1.91%	1.78%	1.86%	1.90%	1.95%
Return On Investment Capital (ROIC_SIMPLE)	-	7.29%	-	-	-	7.37%	-	-	-	7.47%
Cost of Revenue to Revenue	78.20%	73.25%	65.52%	66.79%	71.09%	66.13%	64.11%	64.38%	57.78%	66.01%
SG&A Expenses to Revenue	2.09%	0.78%	2.57%	2.74%	2.10%	2.65%	2.49%	2.68%	2.62%	2.26%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	2.09%	0.78%	2.57%	2.74%	2.10%	2.65%	2.49%	2.68%	2.62%	2.26%
Earnings before Interest and Taxes (EBIT)	82	96	99	82	88	94	96	95	111	93
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	112	126	126	109	116	122	124	123	139	121
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	2.35	2.45	2.46	2.49	2.46	2.81	2.88	2.84	2.90
Price to Tangible Book Value (P/TBV)	0.00	2.40	2.50	2.51	2.55	2.51	2.87	2.94	2.90	2.96
Price to Revenue (P/Rev)	0.00	0.43	0.46	0.52	0.56	0.58	0.67	0.67	0.69	0.70
Price to Earnings (P/E)	0.00	10.71	11.33	12.04	12.40	12.68	14.42	14.01	12.80	12.82
Dividend Yield	9.93%	9.66%	9.33%	9.46%	9.43%	9.65%	8.49%	8.35%	8.41%	8.31%
Earnings Yield	0.00%	9.34%	8.83%	8.31%	8.06%	7.89%	6.93%	7.14%	7.81%	7.80%
Enterprise Value to Invested Capital (EV/IC)	0.00	1.32	1.02	1.37	1.35	1.37	1.42	1.44	1.48	1.51
Enterprise Value to Revenue (EV/Rev)	0.00	1.03	0.75	1.13	1.28	1.27	1.45	1.42	1.38	1.37
Enterprise Value to EBITDA (EV/EBITDA)	0.00	3.47	2.40	3.25	3.40	3.20	3.60	3.48	3.10	3.07
Enterprise Value to EBIT (EV/EBIT)	0.00	4.68	3.16	4.26	4.44	4.18	4.72	4.53	3.99	3.94
Enterprise Value to NOPAT (EV/NOPAT)	0.00	4.71	3.20	4.32	4.50	4.24	4.79	4.60	4.05	4.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	3.52	2.29	3.18	3.46	3.34	4.12	3.88	3.43	3.22
Enterprise Value to Free Cash Flow (EV/FCFF)	0.52	3.53	2.44	3.32	0.00	3.07	5.76	5.40	3.05	3.42
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.44	0.00	0.46	0.46	0.47	0.47	0.48	0.48	0.48
Long-Term Debt to Equity	0.00	0.44	0.00	0.46	0.46	0.47	0.47	0.48	0.48	0.48
Financial Leverage	0.42	0.38	0.27	0.27	0.39	0.33	0.34	0.34	0.33	0.27
Leverage Ratio	1.50	1.52	1.50	1.52	1.56	1.53	1.52	1.54	1.55	1.55
Compound Leverage Factor	1.44	1.45	1.39	1.41	1.44	1.42	1.41	1.43	1.46	1.45
Debt to Total Capital	0.00%	30.66%	0.00%	31.53%	31.70%	31.82%	32.03%	32.37%	32.30%	32.52%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	30.66%	0.00%	31.53%	31.70%	31.82%	32.03%	32.37%	32.30%	32.52%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	46.94%	67.39%	45.95%	45.92%	45.89%	45.68%	45.27%	45.26%	45.01%
Common Equity to Total Capital	0.00%	22.40%	32.61%	22.52%	22.38%	22.29%	22.29%	22.36%	22.44%	22.47%
Debt to EBITDA	0.00	0.85	0.00	0.85	0.84	0.85	0.85	0.82	0.79	0.79
Net Debt to EBITDA	0.00	0.71	0.00	0.52	0.70	0.52	0.73	0.69	0.45	0.41
Long-Term Debt to EBITDA	0.00	0.85	0.00	0.85	0.84	0.85	0.85	0.82	0.79	0.79
Debt to NOPAT	0.00	1.15	0.00	1.13	1.11	1.12	1.13	1.09	1.02	1.03
Net Debt to NOPAT	0.00	0.97	0.00	0.69	0.93	0.69	0.97	0.91	0.59	0.53
Long-Term Debt to NOPAT	0.00	1.15	0.00	1.13	1.11	1.12	1.13	1.09	1.02	1.03
Altman Z-Score	0.00	2.43	2.49	2.25	2.17	2.19	2.37	2.39	2.38	2.34
Noncontrolling Interest Sharing Ratio	68.94%	68.78%	68.72%	68.48%	67.23%	67.51%	67.30%	67.02%	67.04%	67.01%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.00	3.67	4.51	3.33	3.06	4.02	5.21	4.68	4.53	4.35
Quick Ratio	0.00	2.63	4.41	3.27	1.88	3.93	2.90	2.67	4.45	4.27
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	1,367	212	210	187	-1,109	228	36	39	237	159
Operating Cash Flow to CapEx	880.03%	1,415.40%	1,144.60%	2,183.54%	600.39%	838.43%	1,069.94%	1,197.64%	810.95%	983.15%
Free Cash Flow to Firm to Interest Expense	375.08	45.02	28.78	30.61	-172.30	34.43	5.41	5.84	35.35	27.48
Operating Cash Flow to Interest Expense	31.69	26.06	19.80	16.11	15.68	16.24	15.89	18.33	18.82	22.95
Operating Cash Flow Less CapEx to Interest Expense	28.09	24.22	18.07	15.37	13.07	14.30	14.40	16.80	16.50	20.62
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.00	1.12	1.10	0.97	1.88	0.89	0.89	0.91	0.87	0.87
Accounts Receivable Turnover	0.00	12.27	14.92	12.94	0.00	13.29	16.79	18.40	15.92	20.32
Inventory Turnover	0.00	178.62	171.71	181.43	0.00	175.65	151.89	204.13	177.30	168.89
Fixed Asset Turnover	0.00	1.57	1.53	1.37	0.00	1.23	1.23	1.27	1.22	1.23
Accounts Payable Turnover	0.00	25.51	26.67	16.80	0.00	19.89	29.21	23.56	18.96	20.54
Days Sales Outstanding (DSO)	0.00	29.74	24.47	28.21	0.00	27.47	21.74	19.84	22.93	17.97
Days Inventory Outstanding (DIO)	0.00	2.04	2.13	2.01	0.00	2.08	2.40	1.79	2.06	2.16
Days Payable Outstanding (DPO)	0.00	14.31	13.69	21.72	0.00	18.35	12.50	15.49	19.25	17.77
Cash Conversion Cycle (CCC)	0.00	17.48	12.91	8.50	0.00	11.20	11.65	6.13	5.74	2.36
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	0.00	1,239	1,133	1,114	1,195	1,103	1,192	1,169	1,068	1,036
Invested Capital Turnover	0.00	1.23	1.29	1.16	2.11	1.02	1.00	1.04	1.01	1.06
Increase / (Decrease) in Invested Capital	-1,286	-117	-113	-107	1,195	-136	59	55	-127	-67
Enterprise Value (EV)	669	1,634	1,155	1,531	1,617	1,511	1,696	1,688	1,580	1,560
Market Capitalization	669	687	712	702	704	688	782	796	790	800
Book Value per Share	$0.00	$8.29	$8.24	$8.11	$8.01	$7.95	$7.90	$7.84	$7.88	$7.84
Tangible Book Value per Share	$0.00	$8.12	$8.07	$7.94	$7.85	$7.78	$7.73	$7.67	$7.72	$7.67
Total Capital	0.00	1,303	890	1,268	1,261	1,256	1,248	1,235	1,237	1,229
Total Debt	0.00	400	0.00	400	400	400	400	400	400	400
Total Long-Term Debt	0.00	400	0.00	400	400	400	400	400	400	400
Net Debt	0.00	335	-157	246	334	247	344	334	230	207
Capital Expenditures (CapEx)	13	8.66	13	4.51	17	13	9.77	10	16	13
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	114	24	0.57	90	17	126	117	19	-7.32
Debt-free Net Working Capital (DFNWC)	0.00	179	181	154	156	170	181	183	188	186
Net Working Capital (NWC)	0.00	179	181	154	156	170	181	183	188	186
Net Nonoperating Expense (NNE)	3.01	3.81	6.48	5.04	5.15	5.54	5.23	5.38	5.36	4.43
Net Nonoperating Obligations (NNO)	0.00	335	243	246	334	247	344	334	230	207
Total Depreciation and Amortization (D&A)	29	29	27	27	28	28	28	28	28	27
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	7.16%	1.58%	0.04%	7.14%	1.41%	10.75%	9.81%	1.62%	-0.64%
Debt-free Net Working Capital to Revenue	0.00%	11.23%	11.76%	11.39%	12.37%	14.27%	15.52%	15.37%	16.47%	16.34%
Net Working Capital to Revenue	0.00%	11.23%	11.76%	11.39%	12.37%	14.27%	15.52%	15.37%	16.47%	16.34%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.47	$0.42	$0.34	$0.37	$0.41	$0.42	$0.41	$0.51	$0.43
Adjusted Weighted Average Basic Shares Outstanding	0.00	35.22M	35.22M	35.22M	35.23M	35.22M	35.23M	35.23M	35.24M	35.24M
Adjusted Diluted Earnings per Share	$0.00	$0.47	$0.42	$0.34	$0.37	$0.41	$0.42	$0.41	$0.51	$0.43
Adjusted Weighted Average Diluted Shares Outstanding	0.00	35.22M	35.22M	35.22M	35.23M	35.22M	35.23M	35.23M	35.24M	35.24M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	35.22M	35.22M	35.22M	35.23M	35.22M	35.23M	35.23M	35.24M	35.23M
Normalized Net Operating Profit after Tax (NOPAT)	81	95	98	80	86	93	95	93	109	92
Normalized NOPAT Margin	19.59%	25.92%	31.83%	30.40%	26.74%	31.15%	33.33%	32.87%	39.52%	31.65%
Pre Tax Income Margin	18.98%	24.93%	29.79%	28.56%	25.20%	29.35%	31.56%	31.05%	37.66%	30.20%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	22.62	20.44	13.53	13.33	13.60	14.16	14.65	14.27	16.57	16.18
NOPAT to Interest Expense	22.31	20.21	13.39	13.13	13.36	13.96	14.42	14.04	16.34	15.91
EBIT Less CapEx to Interest Expense	19.02	18.60	11.80	12.59	10.98	12.22	13.17	12.74	14.25	13.84
NOPAT Less CapEx to Interest Expense	18.71	18.37	11.66	12.39	10.75	12.03	12.93	12.51	14.02	13.57
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	120.66%	125.05%	130.09%	126.87%	114.22%	112.55%	109.64%	106.42%	107.36%
Augmented Payout Ratio	0.00%	120.66%	125.05%	130.09%	126.87%	114.22%	112.55%	109.64%	106.42%	107.36%

Frequently Asked Questions About Westlake Chemical Partners' Financials

When does Westlake Chemical Partners's fiscal year end?

According to the most recent income statement we have on file, Westlake Chemical Partners' financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Westlake Chemical Partners' net income changed over the last 10 years?

Westlake Chemical Partners' net income were at $369.16 million at the end of 2024, a 10.3% increase from 2023, and a 27.6% decrease since 2014.

What is Westlake Chemical Partners's operating income?

Westlake Chemical Partners's total operating income in 2024 was $390.44 million, based on the following breakdown:

Total Gross Profit: $418.94 million
Total Operating Expenses: $28.50 million

How has Westlake Chemical Partners revenue changed over the last 10 years?

Over the last 10 years, Westlake Chemical Partners' total revenue changed from $1.75 billion in 2014 to $1.14 billion in 2024, a change of -35.1%.

How much debt does Westlake Chemical Partners have?

Westlake Chemical Partners' total liabilities were at $458.64 million at the end of 2024, a 0.4% decrease from 2023, and a 75.4% increase since 2014.

How much cash does Westlake Chemical Partners have?

In the past 10 years, Westlake Chemical Partners' cash and equivalents has ranged from $17.06 million in 2021 to $169.56 million in 2015, and is currently $58.32 million as of their latest financial filing in 2024.

How has Westlake Chemical Partners' book value per share changed over the last 10 years?

Over the last 10 years, Westlake Chemical Partners' book value per share changed from 3.23 in 2014 to 7.84 in 2024, a change of 142.3%.

Related Companies

This page (NYSE:WLKP) was last updated on 4/18/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Westlake Chemical Partners (WLKP) Financials

Frequently Asked Questions About Westlake Chemical Partners' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Westlake Chemical Partners (WLKP) Financials

Annual Income Statements for Westlake Chemical Partners

Quarterly Income Statements for Westlake Chemical Partners

Annual Cash Flow Statements for Westlake Chemical Partners

Quarterly Cash Flow Statements for Westlake Chemical Partners

Annual Balance Sheets for Westlake Chemical Partners

Quarterly Balance Sheets for Westlake Chemical Partners

Annual Metrics and Ratios for Westlake Chemical Partners

Quarterly Metrics and Ratios for Westlake Chemical Partners

Frequently Asked Questions About Westlake Chemical Partners' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools